Cofactor Genomics Announces the Expansion of OncoPrism into Colorectal, Breast, Bladder, and Kidney Cancer Platform Now Covering Majority of Patients with Solid-tumor Cancers Cofactor Genomics ...
ST. LOUIS, December 15, 2025--(BUSINESS WIRE)--Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic ...
ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics announced today OncoPrism for colorectal, breast, bladder, and kidney cancer. This announcement follows recent Medicare coverage of the OncoPrism ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback